• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Cytori Therapeutics, Inc. (XMP) - Financial and Strategic SWOT Analysis Review Product Image

Cytori Therapeutics, Inc. (XMP) - Financial and Strategic SWOT Analysis Review

  • Published: September 2011
  • Region: Global
  • 48 pages
  • GlobalData

FEATURED COMPANIES

  • Aastrom Biosciences, Inc.
  • Bioheart, Inc.
  • Geron Corporation
  • MG Biotherapeutics, LLC
  • Osiris Therapeutics, Inc.
  • MORE

Cytori Therapeutics, Inc. (XMP) - Financial and Strategic SWOT Analysis Review

Summary

Cytori Therapeutics, Inc. (Cytori) is a medical device company, engaged in the development and commercialization of stem and regenerative cell therapies for the treatment of cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions. The company’s primary technology is the patented Celution family of products which processes patients’ adipose-derived stem and regenerative cells (ADRCs) at the point of care. It sells its products directly or through distribution partners in various European countries including Finland, Italy, the Netherlands, Norway, Portugal, Spain, Austria, Belgium, Denmark, Germany, Greece, Sweden, Switzerland, Turkey, and the UK, as well is in select Asian, the Middle Eastern, and eastern European countries. Cytori is headquartered in San Diego, California, the US.

Cytori Therapeutics, Inc. Key Recent Developments

Aug 09, 2011: Cytori Reports Second Quarter Results; Provides Commercial and Product Pipeline Update
Jun 08, 2011: Cytori Reports Sustained Benefits at 18 Months in Cardiac READ MORE >



List of Tables
List of Figures
Section 1 - About the Company
Cytori Therapeutics, Inc. - Key Facts
Cytori Therapeutics, Inc. - Key Employees
Cytori Therapeutics, Inc. - Key Employee Biographies
Cytori Therapeutics, Inc. - Major Products and Services
Cytori Therapeutics, Inc. - Pharmaceutical Pipeline Products Data
Cytori Therapeutics, Inc., Pipeline Products by Therapy Area
Cytori Therapeutics, Inc., Pipeline Products by Development Phase
Cytori Therapeutics, Inc. - Medical Equipment Pipeline Products Data
Cytori Therapeutics, Inc. Pipeline Products by Equipment Type
Cytori Therapeutics, Inc. Pipeline Products by Development Stage
Cytori Therapeutics, Inc. - History
Cytori Therapeutics, Inc. - Company Statement
Cytori Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Cytori Therapeutics, Inc. - Business Description
Cytori Therapeutics, Inc. - SWOT Analysis
SWOT Analysis - Overview
Cytori Therapeutics, Inc. - Strengths
Strength - Proprietary Celution Technology
Strength - Widespread Distribution Network
Strength - Strong Liquidity Position
Strength - Strong Patent Portfolio
Weakness - Limited Product Offering
Weakness - History of Losses
Opportunity - Product Pipeline
Opportunity - Growing Market for Reconstructive Surgery
Opportunity - Changing Demographics
Opportunity - Rising Healthcare Expenditure
Threat - Health Insurance Reimbursement Risks
Threat - Competitive Pressures
Threat - Stringent Government Regulations
Threat - Uncertain R&D Outcomes
Cytori Therapeutics, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Cytori Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Cytori Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
Cytori Therapeutics, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011
Cytori Therapeutics, Inc., Medical Equipment, Deals By Type, 2005 to YTD 2011
Cytori Therapeutics, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Jun 02, 2011: Cytori Receives Cell-Enriched Fat Grafting Patent In Japan
May 17, 2011: Cytori Announces Independent Clinical Study Results In Breast Reconstruction Presented At Association of Breast Surgery Conference
May 06, 2011: Cytori Appoints Clyde W Shores As Executive Vice President, Marketing And Sales
May 05, 2011: Cytori Reports Product Revenues Of $1.4m In Q1 2011
May 04, 2011: Cytori To Install StemSource Cell Bank For Neo Derm In Hong Kong
May 03, 2011: Cytori Announces Management Changes
Mar 10, 2011: Cytori Reports Product Revenues Of $8.2m In 2010
Mar 03, 2011: Cytori Therapeutics Establishes European Sales Headquarters In Switzerland
Mar 02, 2011: Cytori Therapeutics Establishes European Sales Headquarters In Switzerland And Launches Cytori Exchange
Feb 25, 2011: Cytori Receives Japanese Patent For Celution System Technology
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Osiris Therapeutics, Inc.
MG Biotherapeutics, LLC
Geron Corporation
Bioheart, Inc.
Aastrom Biosciences, Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS